Cargando…
Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study
OBJECTIVES: To determine the optimal threshold of blood and urine neutrophil gelatinase-associated lipocalin (NGAL) to predict moderate to severe acute kidney injury (AKI) and persistent moderate to severe AKI lasting at least 48 consecutive hours, as defined by an adjudication panel. METHODS: A mul...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726065/ https://www.ncbi.nlm.nih.gov/pubmed/28698338 http://dx.doi.org/10.1136/bmjopen-2017-016028 |
_version_ | 1783285663628525568 |
---|---|
author | Tecson, Kristen M Erhardtsen, Elisabeth Eriksen, Peter M Gaber, A Osama Germain, Michael Golestaneh, Ladan Lavoria, Maria de los Angeles Moore, Linda W McCullough, Peter A |
author_facet | Tecson, Kristen M Erhardtsen, Elisabeth Eriksen, Peter M Gaber, A Osama Germain, Michael Golestaneh, Ladan Lavoria, Maria de los Angeles Moore, Linda W McCullough, Peter A |
author_sort | Tecson, Kristen M |
collection | PubMed |
description | OBJECTIVES: To determine the optimal threshold of blood and urine neutrophil gelatinase-associated lipocalin (NGAL) to predict moderate to severe acute kidney injury (AKI) and persistent moderate to severe AKI lasting at least 48 consecutive hours, as defined by an adjudication panel. METHODS: A multicentre prospective observational study enrolled intensive care unit (ICU) patients and recorded daily ethylenediaminetetraacetic acid (EDTA) plasma, heparin plasma and urine NGAL. We used natural log-transformed NGAL in a logistic regression model to predict stage 2/3 AKI (defined by Kidney Disease International Global Organization). We performed the same analysis using the NGAL value at the start of persistent stage 2/3 AKI. RESULTS: Of 245 subjects, 33 (13.5%) developed stage 2/3 AKI and 25 (10.2%) developed persistent stage 2/3 AKI. Predicting stage 2/3 AKI revealed the optimal NGAL cutoffs in EDTA plasma (142.0 ng/mL), heparin plasma (148.3 ng/mL) and urine (78.0 ng/mL) and yielded the following decision statistics: sensitivity (SN)=78.8%, specificity (SP)=73.0%, positive predictive value (PPV)=31.3%, negative predictive value (NPV)=95.7%, diagnostic accuracy (DA)=73.8% (EDTA plasma); SN=72.7%, SP=73.8%, PPV=30.4%, NPV=94.5%, DA=73.7% (heparin plasma); SN=69.7%, SP=76.8%, PPV=32.9%, NPV=94%, DA=75.8% (urine). The optimal NGAL cutoffs to predict persistent stage 2/3 AKI were similar: 148.3 ng/mL (EDTA plasma), 169.6 ng/mL (heparin plasma) and 79.0 ng/mL (urine) yielding: SN=84.0%, SP=73.5%, PPV=26.6%, NPV=97.6, DA=74.6% (EDTA plasma), SN=84%, SP=76.1%, PPV=26.8%, NPV=96.5%, DA=76.1% (heparin plasma) and SN=75%, SP=75.8%, PPV=26.1, NPV=96.4%, DA=75.7% (urine). CONCLUSION: Blood and urine NGAL predicted stage 2/3 AKI, as well as persistent 2/3 AKI in the ICU with acceptable decision statistics using a single cut point in each type of specimen. |
format | Online Article Text |
id | pubmed-5726065 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-57260652017-12-19 Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study Tecson, Kristen M Erhardtsen, Elisabeth Eriksen, Peter M Gaber, A Osama Germain, Michael Golestaneh, Ladan Lavoria, Maria de los Angeles Moore, Linda W McCullough, Peter A BMJ Open Renal Medicine OBJECTIVES: To determine the optimal threshold of blood and urine neutrophil gelatinase-associated lipocalin (NGAL) to predict moderate to severe acute kidney injury (AKI) and persistent moderate to severe AKI lasting at least 48 consecutive hours, as defined by an adjudication panel. METHODS: A multicentre prospective observational study enrolled intensive care unit (ICU) patients and recorded daily ethylenediaminetetraacetic acid (EDTA) plasma, heparin plasma and urine NGAL. We used natural log-transformed NGAL in a logistic regression model to predict stage 2/3 AKI (defined by Kidney Disease International Global Organization). We performed the same analysis using the NGAL value at the start of persistent stage 2/3 AKI. RESULTS: Of 245 subjects, 33 (13.5%) developed stage 2/3 AKI and 25 (10.2%) developed persistent stage 2/3 AKI. Predicting stage 2/3 AKI revealed the optimal NGAL cutoffs in EDTA plasma (142.0 ng/mL), heparin plasma (148.3 ng/mL) and urine (78.0 ng/mL) and yielded the following decision statistics: sensitivity (SN)=78.8%, specificity (SP)=73.0%, positive predictive value (PPV)=31.3%, negative predictive value (NPV)=95.7%, diagnostic accuracy (DA)=73.8% (EDTA plasma); SN=72.7%, SP=73.8%, PPV=30.4%, NPV=94.5%, DA=73.7% (heparin plasma); SN=69.7%, SP=76.8%, PPV=32.9%, NPV=94%, DA=75.8% (urine). The optimal NGAL cutoffs to predict persistent stage 2/3 AKI were similar: 148.3 ng/mL (EDTA plasma), 169.6 ng/mL (heparin plasma) and 79.0 ng/mL (urine) yielding: SN=84.0%, SP=73.5%, PPV=26.6%, NPV=97.6, DA=74.6% (EDTA plasma), SN=84%, SP=76.1%, PPV=26.8%, NPV=96.5%, DA=76.1% (heparin plasma) and SN=75%, SP=75.8%, PPV=26.1, NPV=96.4%, DA=75.7% (urine). CONCLUSION: Blood and urine NGAL predicted stage 2/3 AKI, as well as persistent 2/3 AKI in the ICU with acceptable decision statistics using a single cut point in each type of specimen. BMJ Publishing Group 2017-07-10 /pmc/articles/PMC5726065/ /pubmed/28698338 http://dx.doi.org/10.1136/bmjopen-2017-016028 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Renal Medicine Tecson, Kristen M Erhardtsen, Elisabeth Eriksen, Peter M Gaber, A Osama Germain, Michael Golestaneh, Ladan Lavoria, Maria de los Angeles Moore, Linda W McCullough, Peter A Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study |
title | Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study |
title_full | Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study |
title_fullStr | Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study |
title_full_unstemmed | Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study |
title_short | Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study |
title_sort | optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study |
topic | Renal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726065/ https://www.ncbi.nlm.nih.gov/pubmed/28698338 http://dx.doi.org/10.1136/bmjopen-2017-016028 |
work_keys_str_mv | AT tecsonkristenm optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy AT erhardtsenelisabeth optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy AT eriksenpeterm optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy AT gaberaosama optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy AT germainmichael optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy AT golestanehladan optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy AT lavoriamariadelosangeles optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy AT moorelindaw optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy AT mcculloughpetera optimalcutpointsofplasmaandurineneutrophilgelatinaseassociatedlipocalinforthepredictionofacutekidneyinjuryamongcriticallyilladultsretrospectivedeterminationandclinicalvalidationofaprospectivemulticentrestudy |